Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
about
Cancer as a metabolic diseaseMicroarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancerTissue Regeneration in the Chronically Inflamed Tumor Environment: Implications for Cell Fusion Driven Tumor Progression and Therapy Resistant Tumor Hybrid CellsAre hematopoietic stem cells involved in hepatocarcinogenesis?On the origin of cancer metastasisThe phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosisCell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogensCell fusion in the brain: two cells forward, one cell back.Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.Current themes in molecular pediatrics: molecular medicine and its applications.Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogrammingBone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement.Mesenchymal stem cells generate distinct functional hybrids in vitro via cell fusion or entosis.TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.Ploidy reductions in murine fusion-derived hepatocytes.Stem cells in hepatocarcinogenesis: evidence from genomic dataHuman bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury.Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.Reversal of Hepatic Fibrosis by Human CD34(+) Stem/Progenitor Cell Transplantation in RatsFunctional evaluation of ES-somatic cell hybrids in vitro and in vivo.Stem cells, cell transplantation and liver repopulationBone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro.Bone marrow stem cells and liver regenerationLiver cirrhosisSingle-cell analysis of ploidy and centrosomes underscores the peculiarity of normal hepatocytes.Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.From skin cells to hepatocytes: advances in application of iPS cell technologyDe novo generation of white adipocytes from the myeloid lineage via mesenchymal intermediates is age, adipose depot, and gender specific.Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in micePerspectives on the mesenchymal origin of metastatic cancerThe ploidy conveyor of mature hepatocytes as a source of genetic variation.Embryonic stem cells contribute to mouse chimeras in the absence of detectable cell fusionAdipose lineage specification of bone marrow-derived myeloid cells.Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model.Activation of stem cells in hepatic diseases.CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar.Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity.The potential of cell fusion for human therapy.
P2860
Q21245061-ED297DCB-A82E-4023-A935-17765A3F66EBQ24528253-D0849436-329D-40C6-A99F-9A665B2DB8B0Q26772032-4469A4CD-EBAE-4D47-9568-897B4CCFC4E1Q26830307-0262D763-3B4E-4497-B068-6BB3FC6FC5DAQ26865675-B0A00C0B-061C-4E4E-AEFF-5BEE53FCA3ACQ27026037-36240D21-2DBE-4E6E-ACF8-64743B841237Q27487009-DDF37DB3-61EC-4633-86A3-A58F09E789D3Q27691973-B27C6A5B-5ADA-4724-94C5-8EB3A072A746Q30319983-69356CD1-6D17-4058-88AB-BBF7B5FB05E4Q30397005-7BF20B63-B609-4976-B434-718A518B342FQ30499750-AAE4BFCC-F9DB-4A9A-ADB9-16060F31125DQ30552419-31C4B136-99AE-4A1A-AA5D-66A982533BA8Q30828088-35EF10F8-1BF5-420D-99E9-071D8F560052Q33281667-4BB86265-D870-48A8-837A-0CCAB4BA5E64Q33410782-4D6BC091-C507-4638-9D89-C17EF9A0AE22Q33533408-2451DFBD-0FD6-4391-925A-B30FFC1B9039Q33580844-2BBE6008-0793-4E5C-86DB-560681633810Q33590816-48138C0E-5447-4960-9002-5B20842AA7EBQ33614914-96556C88-A955-457E-A15B-1A8DB8F8564BQ33648749-946A6759-2496-4D6E-A81A-64F62A4B5064Q33801245-06305C5E-F49D-44BB-A84D-084B78F24A2DQ33818431-B7BE8B7D-7424-4EB7-B2B8-A5377C0414F8Q33830949-D2E9741C-BFD1-4D6C-9E83-654D58B4203FQ33903059-61315EE5-B2D0-472C-ABAD-0A10D30DB31AQ34010340-47D12B88-6F24-4585-BFE4-D9DDC3CCFAECQ34055959-309932EB-07B6-4077-AFF0-285F96F95530Q34090220-9D8B0F2C-62A4-49C1-8F03-DEE8301EF4B4Q34090265-3542EDAA-99BB-4F1A-BE0D-5690FB941932Q34093108-E3F22DC1-7300-411C-86F9-2D049DB74496Q34142453-AC9ADFE8-4709-4588-8AA6-3C3AE0E35AA0Q34233764-8A5DB816-649C-4FFC-862F-2A2DAD02FF13Q34259413-F3CBD936-D543-40A8-99AC-065C38BA962CQ34309982-68D26804-EAB4-434B-B5CB-C285BAE89B66Q34346254-8D5FCA40-4FA8-4FF9-BE05-F73C41D84CA3Q34539733-0128D646-620C-4CE8-9A8A-74466C708C7EQ34554113-8A03A816-0CCA-4126-8E13-9CB003DE3C62Q34569461-819205DA-D978-44C1-9E06-5F02C17E815DQ34570650-C701D153-98BF-478B-A467-228462FBB0CEQ34609741-B32090E9-2900-407E-B572-0ABA82D4DCAEQ34686121-0453104E-4AC5-4258-80C4-E45BA6C94800
P2860
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@en
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@nl
type
label
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@en
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@nl
prefLabel
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@en
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@nl
P2093
P2860
P356
P1433
P1476
Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.
@en
P2093
Alexis S Bailey
Craig Dorrell
Holger Willenbring
Mark Foster
Markus Grompe
Milton Finegold
Susan Olson
William H Fleming
Yassmine Akkari
P2860
P2888
P304
P356
10.1038/NM1062
P407
P577
2004-06-13T00:00:00Z